Colgate-Palmolive Company $CL Shares Purchased by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. grew its position in shares of Colgate-Palmolive Company (NYSE:CL) by 1.2% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,850,538 shares of the company’s stock after buying an additional 21,230 shares during the period. Sumitomo Mitsui Trust Group Inc. owned approximately 0.23% of Colgate-Palmolive worth $157,888,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. State Street Corp increased its position in Colgate-Palmolive by 97.4% during the second quarter. State Street Corp now owns 94,195,992 shares of the company’s stock worth $8,635,889,000 after acquiring an additional 46,476,510 shares during the period. Bank of New York Mellon Corp boosted its holdings in Colgate-Palmolive by 172.5% in the 1st quarter. Bank of New York Mellon Corp now owns 12,521,545 shares of the company’s stock valued at $1,067,211,000 after purchasing an additional 7,927,238 shares during the period. Bank of America Corp DE bought a new stake in Colgate-Palmolive in the 2nd quarter valued at about $567,483,000. Envestnet Asset Management Inc. grew its position in shares of Colgate-Palmolive by 266.5% during the 2nd quarter. Envestnet Asset Management Inc. now owns 4,146,337 shares of the company’s stock worth $380,136,000 after purchasing an additional 3,014,860 shares in the last quarter. Finally, Assenagon Asset Management S.A. grew its position in shares of Colgate-Palmolive by 151.4% during the 3rd quarter. Assenagon Asset Management S.A. now owns 4,276,774 shares of the company’s stock worth $364,894,000 after purchasing an additional 2,575,530 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Trending Headlines about Colgate-Palmolive

Here are the key news stories impacting Colgate-Palmolive this week:

• Positive Sentiment: Third-quarter adjusted earnings were $0.97 per share, above the roughly $0.92–$0.93 analyst consensus and up from $0.91 a year earlier. Revenue increased 4.6% year over year to $5.37 billion, also exceeding expectations. Colgate-Palmolive Surpasses Q3 Earnings and Revenue Estimates
• Positive Sentiment: Organic sales growth, pricing, higher volumes and productivity initiatives supported the quarterly beat. Management raised its 2026 base-business EPS and gross-margin outlook, signaling better profitability despite cost pressures. Colgate Q3 Earnings Beat Estimates on Organic Sales and Pricing Gains
• Positive Sentiment: The company maintained its fiscal 2026 EPS outlook while improving its base-business profitability forecast. The stronger guidance likely explains the favorable investor reaction and elevated trading activity. Colgate-Palmolive Raises FY26 Base-Business EPS View
• Neutral Sentiment: Management narrowed its full-year sales-growth outlook, suggesting that pricing and productivity—not broad-based demand—remain important drivers of performance. Colgate-Palmolive Raises Profit Outlook Despite Weak US Demand
• Negative Sentiment: Weak U.S. demand and rising input costs remain risks. The earnings beat was strong, but investors may question how sustainable margin gains will be if consumer demand softens or cost inflation accelerates. Colgate-Palmolive Q3 Analysis

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on the stock. Weiss Ratings downgraded shares of Colgate-Palmolive from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, October 2nd. Raymond James Financial increased their price target on Colgate-Palmolive from $100.00 to $102.00 and gave the stock an “outperform” rating in a research report on Monday, August 3rd. Wells Fargo & Company lowered their price objective on Colgate-Palmolive from $95.00 to $90.00 and set an “equal weight” rating on the stock in a research note on Monday, October 5th. Barclays upped their target price on Colgate-Palmolive from $80.00 to $87.00 and gave the company an “equal weight” rating in a research report on Tuesday, July 21st. Finally, Piper Sandler reduced their target price on Colgate-Palmolive from $98.00 to $95.00 and set an “overweight” rating on the stock in a report on Monday, September 21st. Thirteen equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. Based on data from MarketBeat.com, Colgate-Palmolive currently has an average rating of “Moderate Buy” and an average target price of $98.89.

Insider Buying and Selling

In related news, Director John Cahill sold 4,170 shares of the firm’s stock in a transaction dated Thursday, August 6th. The stock was sold at an average price of $93.37, for a total value of $389,352.90. Following the sale, the director directly owned 28,373 shares of the company’s stock, valued at $2,649,187.01. This trade represents a 12.81% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, COO Panagiotis Tsourapas sold 10,000 shares of Colgate-Palmolive stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $92.05, for a total value of $920,500.00. Following the completion of the transaction, the chief operating officer owned 64,901 shares in the company, valued at approximately $5,974,137.05. This represents a 13.35% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 175,191 shares of company stock worth $16,110,903 in the last ninety days. 0.43% of the stock is owned by insiders.

Colgate-Palmolive Stock Performance

Shares of NYSE:CL opened at $95.35 on Monday. The company’s 50 day simple moving average is $89.54 and its 200 day simple moving average is $89.65. The stock has a market capitalization of $76.01 billion, a price-to-earnings ratio of 37.39, a price-to-earnings-growth ratio of 4.59 and a beta of 0.31. The company has a debt-to-equity ratio of 13.82, a current ratio of 0.46 and a quick ratio of 0.30. Colgate-Palmolive Company has a 1 year low of $74.54 and a 1 year high of $99.33.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, October 30th. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.93 by $0.04. The firm had revenue of $5.37 billion during the quarter, compared to analysts’ expectations of $5.34 billion. Colgate-Palmolive had a return on equity of 607.88% and a net margin of 9.65%. The company’s quarterly revenue was up 4.6% on a year-over-year basis. During the same period in the prior year, the company earned $0.91 earnings per share. As a group, research analysts predict that Colgate-Palmolive Company will post 3.89 EPS for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Tuesday, October 20th will be issued a dividend of $0.53 per share. The ex-dividend date of this dividend is Tuesday, October 20th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.2%. Colgate-Palmolive’s payout ratio is 84.13%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (NYSE: CL) is a global consumer products company focused on oral care, personal care, home care and pet nutrition. Its portfolio includes toothpaste, toothbrushes, mouthwash, liquid hand soap, body wash, deodorants, household cleaning products and pet food and treats.

The company markets well-known brands such as Colgate, Palmolive, elmex, meridol, Softsoap, Irish Spring, Ajax, Protex and Hill’s Science Diet. Colgate-Palmolive also provides veterinary and nutritional products through Hill’s Pet Nutrition, which serves pet owners and animal health professionals.

Founded in 1806 by William Colgate, the company developed from a soap and candle business into a diversified consumer goods manufacturer.